Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure

By LabMedica International staff writers
Posted on 02 Aug 2023

Heart failure, a condition that will affect one in five individuals during their lifetime, is significantly associated with kidney impairments. More...

As such, monitoring kidney health indicators in individuals susceptible to heart failure is standard practice. While short-term fluctuations in renal biomarkers are well-established, the link between long-term biomarker patterns and heart failure risk is yet to be understood. Now, researchers have discovered a key treatment target that could potentially prevent patients from developing serious heart conditions in the future.

In a new study, an international research team led by Osaka University (Suita, Japan) has successfully identified long-term trends in kidney health indicators among healthy European adults, and how these patterns influence the risk of new-onset heart failure. The research involved the examination of two prevalent kidney health markers—urinary albumin excretion (UAE) and serum creatinine—in nearly 7000 participants from the Dutch study Prevention of Renal and Vascular End-stage Diseases (PREVEND). The team monitored the trends in UAE and serum creatinine levels over an 11-year period, investigating their correlation with new-onset heart failure and death.

The study clearly revealed that the majority of participants exhibited stable low UAE or serum creatinine levels, but those with consistently high UAE were at a significantly increased risk of new-onset heart failure or all-cause mortality. Interestingly, annual levels of renal biomarkers remained notably stable year after year throughout the 11-year follow-up period. Stable serum creatinine levels over time correlated with heart failure, but not with an elevated risk of death. A more in-depth analysis revealed that individuals with consistently higher UAE or serum creatinine levels were more likely to be older, male, and to have conditions like diabetes, previous heart attack, or dyslipidemia. The study implies that reducing UAE could help decrease the risk of future heart failure and death in these patients. Given that heart failure is likely to affect one in five people during their lifetime, these findings could significantly influence preventive medicine and further validation of these results is required in non-European populations.

“Our results highlight the importance of the heart-kidney link in heart failure by showing that patients with persistently worse renal function, as indicated by higher UAE or serum creatinine levels, are at a higher risk of heart failure or mortality,” said Dr. Ryoto Sakaniwa, lead author of the study. “Reducing these renal biomarkers could help prevent heart failure.”

Related Links:
Osaka University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.